A Study to See if New Device Technology Can Tell the Difference Between Non-cancer and Cancerous Melanoma


About this study

The purpose of this study is to use new technology called Optical Transfer Diagnosis (OTD) to find if skin lesions are melanomas or non cancer. The research study team wants to see if the Balter Medical OTD technology will identify these lesions the same or better than a dermatologist.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • A total of 300 patients in sets of 50 patients
  • Individuals capable of giving informed consent
  • Over the age of 17
  • Biopsy or excision of suspicious pigmented lesions is planned
  • Women who are pregnant and/or nursing may take part in this study

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

David Swanson, M.D.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer